SBFM Q3 2021 Earnings — Sunshine Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

SBFMSunshine Biopharma, Inc.

$6M

Q3 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$50,376+193.7% YoY

Gross Profit

$30,87061.3% margin

Operating Income

-$496,000-984.6% margin

Net Income

-$4M-8017.7% margin

EPS (Diluted)

$-3180.00

QoQ Revenue Growth

-4.7%

Cash Flow

Operating Cash Flow

-$600,808

Free Cash Flow

-$600,808

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$3M

Total Liabilities

$4M

Stockholders' Equity

-$1M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50,376	$17,150	+193.7%
Gross Profit	$30,870	$10,810	+185.6%
Operating Income	-$496,000	-$67,288	-637.1%
Net Income	-$4M	-$698,595	-478.2%